China Digest: Exegenesis, Sandstar in funding news

China Digest: Exegenesis, Sandstar in funding news

Gene therapy company Exegenesis Bio has secured $20 million in a Series B round led by Lenovo Group’s Legend Capital. In a separate development, smart retail solution provider SandStar has garnered ‘tens of millions of US dollars’ in a Series B+ round of financing from Thailand’s True Digital Group.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter